New oil could boost liver cancer treatment

NCT ID NCT05435014

Terminated Disease control Sponsor: T-ACE Medical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new oil called T-ACE Oil, mixed with a chemotherapy drug, for people with liver cancer that cannot be removed by surgery. The oil is injected directly into the liver's blood vessels to block them and deliver chemo to the tumor. The trial aims to see if it is safe and works better than standard treatments. It is currently on hold.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: T-ACE Oil (a special oil mixed with the chemotherapy drug doxorubicin)
What this could lead to: If it works, this could offer a more effective way to treat liver cancer that cannot be removed by surgery, potentially improving tumor control.
What could go wrong: This is a very early (Phase 1/2) trial that is currently suspended, so results are uncertain. The treatment carries risks like blood clots in the lungs or brain, and it may not work better than existing options.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOCELLULAR CARCINOMA

Contacts and locations

Locations

Kaohsiung Veterans General Hospital

Kaohsiung City, 813, Taiwan
National Cheng Kung University Hospital

Tainan, 701, Taiwan
National Taiwan University Hospital

Taipei, 100, Taiwan
Tungs' Taichung Metroharbor Hospital

Taichung, 435, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.